Invesco Pharmaceuticals ETF
PJP
PJP
97 hedge funds and large institutions have $194M invested in Invesco Pharmaceuticals ETF in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 28 increasing their positions, 38 reducing their positions, and 8 closing their positions.
Holders
97
Holders Change
+4
Holders Change %
+4.3%
% of All Funds
2.59%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
28
Reduced
38
Closed
8
Calls
$691K
Puts
$348K
Net Calls
+$343K
Net Calls Change
+$313K
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$21.1M |
| 2 |
MWM
2
Merriman Wealth Management
Seattle,
Washington
|
$5.41M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$30M |
| 4 |
4
Goldman Sachs
New York
|
$3.78M |
| 5 |
AG
5
Advisor Group
Phoenix,
Arizona
|
$3.42M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Stifel Financial
St. Louis,
Missouri
| – | – | -3,414 | Closed |
|
|
CLOS
102
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | – | -1,500 | Closed |
|
|
TFA
103
Transamerica Financial Advisors
St. Petersburg,
Florida
| – | – | -280 | Closed |
|
104
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| – | – | -250 | Closed |
|
|
PG
105
Patten Group
Chattanooga,
Tennessee
| – | – | -67 | Closed |
|
106
Parallax Volatility Advisers
San Francisco,
California
| $0 | 1 | – | – |
|
|
ACM
107
Argentus Capital Management
Dallas,
Texas
| – | – | – | – |
|